NO168357C - Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfider - Google Patents
Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfiderInfo
- Publication number
- NO168357C NO168357C NO860908A NO860908A NO168357C NO 168357 C NO168357 C NO 168357C NO 860908 A NO860908 A NO 860908A NO 860908 A NO860908 A NO 860908A NO 168357 C NO168357 C NO 168357C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogue procedure
- disulfides
- active disulfides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853508666 DE3508666A1 (de) | 1985-03-12 | 1985-03-12 | Heterocyclische disulfide und ihre anwendung als immunmodulatoren |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO860908L NO860908L (no) | 1986-09-15 |
| NO168357B NO168357B (no) | 1991-11-04 |
| NO168357C true NO168357C (no) | 1992-02-12 |
Family
ID=6264871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860908A NO168357C (no) | 1985-03-12 | 1986-03-11 | Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfider |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0194571B1 (es) |
| JP (1) | JPH0751572B2 (es) |
| KR (1) | KR940001773B1 (es) |
| AR (1) | AR245113A1 (es) |
| AT (1) | ATE58293T1 (es) |
| AU (1) | AU594943B2 (es) |
| DE (2) | DE3508666A1 (es) |
| DK (1) | DK165181C (es) |
| ES (3) | ES8801506A1 (es) |
| FI (1) | FI860980A (es) |
| GR (1) | GR860649B (es) |
| HU (1) | HU201742B (es) |
| IE (1) | IE58729B1 (es) |
| IL (1) | IL78091A (es) |
| NO (1) | NO168357C (es) |
| NZ (1) | NZ215424A (es) |
| PH (1) | PH22275A (es) |
| PT (1) | PT82166B (es) |
| ZA (1) | ZA861780B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3915094A1 (de) | 1989-05-09 | 1991-01-10 | Hoechst Ag | Verfahren zur herstellung von 2-mercapto-4-methyl-1,3-thiazol-5-yl-essigsaeure und deren ester |
| TW252112B (es) * | 1993-08-19 | 1995-07-21 | Pfizer | |
| DE10055219A1 (de) * | 2000-11-08 | 2002-05-29 | Bayer Ag | Verfahren zur Herstellung von Dithiazolyldisulfiden |
| US8163776B2 (en) | 2001-01-10 | 2012-04-24 | Grassetti Family Trust | Method of immunomodulation using thione-forming disulfides |
| DE102005004472A1 (de) * | 2005-01-31 | 2006-08-10 | Rhein Chemie Rheinau Gmbh | Verfahren zur Herstellung von Bis-DMTD |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5680M (es) * | 1966-08-19 | 1968-01-08 | ||
| US4378364A (en) * | 1970-05-05 | 1983-03-29 | Grassetti Davide R | Postoperative treatment of carcinoma patients |
| IL36587A (en) * | 1970-05-05 | 1977-10-31 | Grassetti D | Compositions containing pyridine derivatives and their use in a method of modifying cellular surface reactions |
| GB1365943A (en) * | 1970-09-16 | 1974-09-04 | Gaf Corp | Metalworking additive and composition and process for making the same |
| GB1327467A (en) * | 1970-10-12 | 1973-08-22 | Merck & Co Inc | Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase |
| FR2403798A1 (fr) * | 1977-09-22 | 1979-04-20 | Rorer Inc William H | Compositions synergiques a base de disulfure de bis(2-pyridyl-1-oxyde et leur utilisation pour leur activite anti-inflammatoire |
| US4152439A (en) * | 1978-01-12 | 1979-05-01 | Davide R. Grassetti | Stimulant and antidepressant agents |
| DE2944225A1 (de) * | 1979-11-02 | 1981-05-07 | Akzo Gmbh, 5600 Wuppertal | Verfahren zur herstellung von dithiazoldisulfiden |
| US4451471A (en) * | 1981-03-18 | 1984-05-29 | Ciba-Geigy Corporation | Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same |
| DE3118128A1 (de) * | 1981-05-07 | 1982-12-02 | Bayer Ag, 5090 Leverkusen | Verwendung von disulfiden als lipoxygenasehemmer und diese enthaltende arzneimittel |
| ATE12730T1 (de) * | 1981-10-21 | 1985-05-15 | Beecham Group Plc | Topische bakterizide zusammensetzungen. |
| HU193951B (en) * | 1985-03-11 | 1987-12-28 | Richter Gedeon Vegyeszet | Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them |
-
1985
- 1985-03-12 DE DE19853508666 patent/DE3508666A1/de not_active Withdrawn
-
1986
- 1986-03-05 EP EP86102901A patent/EP0194571B1/de not_active Expired - Lifetime
- 1986-03-05 DE DE8686102901T patent/DE3675561D1/de not_active Expired - Fee Related
- 1986-03-05 AT AT86102901T patent/ATE58293T1/de not_active IP Right Cessation
- 1986-03-07 AR AR86303344A patent/AR245113A1/es active
- 1986-03-10 DK DK108786A patent/DK165181C/da active
- 1986-03-10 ES ES552840A patent/ES8801506A1/es not_active Expired
- 1986-03-10 FI FI860980A patent/FI860980A/fi not_active Application Discontinuation
- 1986-03-10 HU HU861011A patent/HU201742B/hu not_active IP Right Cessation
- 1986-03-10 IL IL78091A patent/IL78091A/xx not_active IP Right Cessation
- 1986-03-10 PH PH33495A patent/PH22275A/en unknown
- 1986-03-10 GR GR860649A patent/GR860649B/el unknown
- 1986-03-10 NZ NZ215424A patent/NZ215424A/xx unknown
- 1986-03-11 NO NO860908A patent/NO168357C/no unknown
- 1986-03-11 AU AU54605/86A patent/AU594943B2/en not_active Ceased
- 1986-03-11 ZA ZA861780A patent/ZA861780B/xx unknown
- 1986-03-11 IE IE63086A patent/IE58729B1/en not_active IP Right Cessation
- 1986-03-11 PT PT82166A patent/PT82166B/pt not_active IP Right Cessation
- 1986-03-11 JP JP61051594A patent/JPH0751572B2/ja not_active Expired - Lifetime
- 1986-03-12 KR KR1019860001768A patent/KR940001773B1/ko not_active IP Right Cessation
-
1987
- 1987-07-07 ES ES557614A patent/ES8801624A1/es not_active Expired
- 1987-07-07 ES ES557615A patent/ES8801625A1/es not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO170480C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater | |
| NO169493C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive peptid-derivater | |
| NO171209C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere | |
| NO864425L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater | |
| NO172048C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoler | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO170482C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater | |
| NO171592C (no) | Fremgangsmaate for fremstilling av aktive cinnolin-derivater | |
| NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| NO164295C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. | |
| NO863373D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO168644C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive n-(pyrrol-1-yl)pyridinaminer | |
| NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
| NO864101L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO171108C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater | |
| NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
| NO170012C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider |